期刊文献+

代谢型谷氨酸受体5对创伤性神经元损伤保护作用研究 被引量:2

Protection of mGluR5 agonists against traumatic neuronal injury
下载PDF
导出
摘要 目的研究代谢型谷氨酸受体5(mGluR5)的特异性激动剂对创伤性脑损伤后神经元的保护作用,并初步探讨其作用机制。方法原代培养2 w大鼠皮层神经元细胞,采用神经元机械性损伤模型,加入两种mGluR5特异性激动剂2-氯-5羟苯基甘氨酸(CHPG)和3-氰-氮苯甲酰胺(CDPPB),通过乳酸脱氢酶(LDH)释放率、caspase-3活性检测,研究mGluR5激动剂对神经元损伤可能具有的保护作用;通过western-blot检测细胞外信号调节激酶(ERK)、c-Jun氨基末端激酶(JNK)、p38表达变化并研究这种保护作用的产生机制。结果损伤后LDH释放率和caspase-3活性显著增加,CHPG和CDPPB明显抑制了LDH的释放率和caspase-3的活性,并呈剂量依赖性;Western blot结果提示,CHPG和CDPPB显著增加了ERK的磷酸化水平,而对JNK、p38无影响。结论 mGluR5的激动剂CHPG和CDPPB对机械性神经元损伤具有保护作用,这种保护作用可能是通过激活ERK通路实现。 Objective To investigate the neuroprotection of specific metabotropic glutamate receptor 5 (mGluRS) specific agonist on traumatic brain injury and its mechanism. Methods Cortical neurons were cultured for 2 w. Lactate dehydrogenase (LDH) and caspase-3 activity assay were used to examine the neuroprotectoon of two mGluR5 specific agonists including ( R, S )-2-chloro-5-hydroxy-phenylgcine (CHPG) and 3-cyano-N- ( 1,3-diphenyl- lH-pyrazol-5-yl)-Benzamide (CDPPB) after mechanical neuronal injury. Western blot was used to detect the expression changes of extracellular signal-regulated kinase (ERK), c-jun amino acid terminal kinase (JNK), and p38 and elucidate the mechanism underlying the neuroprotection of CHPG and CDPPB. Results LDH release and caspase-3 activity were increased after mechanical neuronal injury. Pretreatment with CHPG and CDPPB reduced the elevation of LDH release and caspase-3 activity in a dose-dependent manner. Western blot analysis indicated that pretreatment with CHPG and CDPPB significantly elevated the phosphorylation of ERK, but did not affect the phosphorylation of JNK and p38. Conclusion Two mGluR5 agonists, CHPG and CDPPB, have protective effects on mechanical neuronal injury, which might be regulated by ERK pathway.
出处 《中华神经外科疾病研究杂志》 CAS 2013年第1期20-24,共5页 Chinese Journal of Neurosurgical Disease Research
基金 国家自然科学基金资助项目(30930093)
关键词 代谢型谷氨酸受体5 激动剂 ERK 神经元损伤 Metabotropic glutamate receptor 5 Agonist ERR, Neuron injury
  • 相关文献

参考文献17

  • 1Jordan BD. Genetic influences on outcome following traumatic brain injury [J]. Neurochem Res, 2007, 32(4 -5) : 905 -915.
  • 2Choi DW. Glutamate neurotoxicity and diseases of the nervous system [J]. Neuron, 1988, 1(8) : 623 -634.
  • 3Fei Z, Zhang X, Bai HM, et al. Posttraumatic secondary brain insults exacerbates neuronal injury by altering metabotropic glutamate receptors [J]. BMC Neuroscience, 2007, 8: 96.
  • 4Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure anal pharmacology [J]. Psychopharmacology, 2005, 179( 1 ) : 4 - 29.
  • 5Nicoletti F, Bruno V, Copani A, et al. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders [J]. Trends Neurosci, 1996, 19(7) : 267 -271.
  • 6DAntoni S, Berretta A, Bonaccorso CM, et al. Metabotropic glutamate receptors in glial cells EJ]. Neurochem Res, 2008, 33( 12): 2436- 2443.
  • 7Morin N, Gregoire L, Gomez-Mancilla B, et al. Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys [J]. Neuropharmacology, 2010, 58(7): 981 - 986.
  • 8Faden AI, OLeary DM, Fan L, et al. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improve so outcome after brain trauma [ J ]. Exp Neurol, 2001, 167 ( 2 ) : 435 - 444.
  • 9Bittigau P, Ikonomidou C. Glutamate in neurologic diseases [ J ]. J Child Neurol, 1997, 12(8) : 471 - 485.
  • 10Movsesyan VA, Stoica BA, Faden AI. MGluR5 activation reduces beta- amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochromec and apoptosis inducing factor [ J ]. J Neurochem, 2004, 89(6): 1528-1536.

二级参考文献10

  • 1Bullock R. Excitatory amino acids following brain injury [J]. J Neurosurg, 1994, 80 : 595-596.
  • 2Bullock R, Zauner A, Woodward JJ, et al. Factors affecting excitatory amino acid release following severe human head injury [J]. J Neurosurg, 1998, 89: 507-518.
  • 3Foda MA, Marmarou A. A new model of diffuse brain injury in rats [J]. J Neurosurg, 1994, 80: 301-13.
  • 4Humm JL, Kozlowski DA, Bland ST, et al. Use-dependent exaggeration of brain injury: is glutamate involved [J]? Exp Neurol, 1999, 157: 349-358.
  • 5Monyer H, Giffard RG, Hartley DM, et al. Oxygen or glucose deprivation-induced neuronal injury in cortical cell cultures is reduced by tetanus toxin [J]. Neuron, 1992, 8: 967-973.
  • 6McDonald JW, Fix AS, Tizzano JP, et al. Seizures and brain injury in neonatal rats induced by 1s, 3g-ACPD, ametabotropic glutamate receptor agonist [J]. J Neurosci, 1993, 13: 4445-4455.
  • 7Nicoletti F, Bruno V, Copani A, et al. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders [J]. Trends Neurosci, 1996, 19: 267-271.
  • 8Opitz T, Richter P, Reymann KG. The metabotropic glutamate receptor antagonist(α-methyl-4-carboxyphenylglycine) protects hippocampal CA1neurons of the rat from in vitro hypoxia / hypoglycemia [J]. Neuropharmacology, 1994, 33:715-717.
  • 9Fei Zhou, Zhang Xiang, Lu Peiling, et al. The expression and changes of heat shock protein 70, MDA and hemorheology in rat cortex after diffuse axonal injury with secondary insults [J]. J Clin Neurosci, 2001, 8 : 250-252.
  • 10费舟,章翔,李树合,刘先珍,梁景文,李智勇.弥漫性脑损伤合并二次脑损伤脑组织谷氨酸及环核甘酸的改变[J].第四军医大学学报,2000,21(9):1064-1066. 被引量:17

共引文献25

同被引文献35

  • 1胡优敏,董莉,孙碧英,李倩,王小芳,施渭彬,戎伟芳.促代谢型谷氨酸受体mGluR5参与膀胱的生理与伤害性感受[J].科技导报,2006,24(12):23-27. 被引量:1
  • 2Yin S, Niswender CM. Progress toward advanced under- standing of metabotropic glutamate receptors : structure, signaling and therapeutic indications [ J ]. Cell Signal, 2014, 26:2284-2297.
  • 3Chong ZZ, Li F, Maiese K. Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, Bim, and beta-catenin during oxidative stress[J]. C,rr Nurovasc Res. 2006_ 3.107-117.
  • 4Kim JH, Perry C, Luikinga S, et al. Extinction of a co- caine-taking context that protects against drug-primed rein- statement is dependent on the metabotropic glutamate [ J ].Addict Biol, 2014,9. doi: 101 lll/abd. 12142. [ Epub a- head of print].
  • 5Picker MJ, Daugherty D, Henry FE, et al. Metabotropic glutamate antagonists alone and in combination with mor- phine: comparison across two model of persistent, inflam- matory pain [ J ]. Behav Pharmacol, 2011, 22:785- 793.
  • 6Vallano A, Femandez-Duenas V, Garcia-Negredo G, et al. Targeting striatal metabotropic glutamate receptor type 5 in Parkinson's disease: bridging molecular studies and clinical trials [ J ]. CNS Neurol Disord Drug Targets, 2013, 12 :1128-1142.
  • 7Melancon B J, Tarr JC, Panarese JD, et al. Allosteric mod- ulation of the M1 muscarinic acetylcholine receptor: impro- ving cognition and a potential treatment for schizophrenia and Alzheimer's disease [ J ]. Drug Discov Today, 2013, 18:1185-1199.
  • 8Noetzel M J, Jones CK, Conn PJ. Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signaling[ J]. Discov Med, 2012, 14:335-343.
  • 9Handford CE, Tan S, Lawrence A J, et al. The effect of the mGlu5 negative allosteric modulator MTEP and NMDA receptor partial agonist D-cycloserine on Pavlovian condi- tioned fear[ J ]. Int J Neuropsychopharmacol, 2014, 27 : 1-12.
  • 10Pa|ucha-Poniewiera A, Wierofaska JM, Brafaski P, et al. Is the mGlu5 receptor a possible target for new antidepres- sant drugs? [J]. Pharmacol Rep, 2013,65:1506-1511.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部